Product Information

RASAGILINE MESYLATE 0.5 MG TAB is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.4545 per EA under NDC 00093306056. Its NADAC has been published 475 times since Jul 19, 2017.

FDA first approved this application on May 16, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RASAGILINE MESYLATE 0.5 MG TAB

Rasagiline
$0.4545per EA

Strength

.5 mg/1

NDC

00093306056

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

RASAGILINE MESYLATE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021641

FDA Approved

5/16/2006

TE Code

AB

On Market Since

1/3/2017

Pharmacological Classes

Monoamine Oxidase Inhibitor
Monoamine Oxidase Inhibitors

Price Statistics

The NADAC for RASAGILINE MESYLATE 0.5 MG TAB has been published 475 times since Jul 19, 2017, and over the history we have for it it has declined 95.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4545 per EA
All-time high$12.3558 (Jan 10, 2018)
All-time low$0.4545 (Aug 19, 2026)
52-week high$1.2855
52-week low$0.4545
Median price$2.9293
Average price$3.9595
Largest weekly change-54.6% (May 22, 2024)
Weeks tracked475
Tracking sinceJul 19, 2017

Price History

1W

-21.6%

1M

-31.8%

3M

-41.9%

6M

-61.9%

1Y

-59.4%

3Y

-76.2%

5Y

-85.0%

All

-95.8%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of RASAGILINE MESYLATE 0.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for RASAGILINE MESYLATE 0.5 MG TAB, manufactured by Teva Pharmaceuticals USA Inc., is $0.4545 per EA (NDC 00093306056), effective Aug 19, 2026.

How has the price of RASAGILINE MESYLATE 0.5 MG TAB changed over time?

Over the history we have for it, the NADAC for RASAGILINE MESYLATE 0.5 MG TAB has declined 95.8%. It has been tracked across 475 weekly CMS publications since Jul 19, 2017.

What are the highest and lowest recorded NADAC prices for RASAGILINE MESYLATE 0.5 MG TAB?

Since Jul 19, 2017, the NADAC for RASAGILINE MESYLATE 0.5 MG TAB has ranged from a low of $0.4545 (Aug 19, 2026) to a high of $12.3558 (Jan 10, 2018), with a median of $2.9293 per EA.

Are there cheaper alternatives to RASAGILINE MESYLATE 0.5 MG TAB?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RASAGILINE MESYLATE 0.5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures RASAGILINE MESYLATE 0.5 MG TAB?

RASAGILINE MESYLATE 0.5 MG TAB (NDC 00093306056) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.